aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Quick Stats
Jan 30, 202658.7
AI Score
HOLD1.64
Volume Ratio
Mar 12, 2026
Next Earnings
15
+ve Days (30d)
15
-ve Days (30d)
ATYR Stock Summary
Last updated Jan 30, 2026
ATYR is currently trading at $0.8828, positioned below its 200-day moving average of $2.86, suggesting bearish momentum. The stock has a 52-week range of $0.64 to $7.29.
Technical Analysis: The 50-day moving average stands at $0.74, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 67.532, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.105, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ATYR at 58.7/100 with a HOLD recommendation.
ATYR (aTyr Pharma, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 67.532 |
| CMF (20) | 0.105 |
| ROC (10) | 24.954 |
| ADX (14) | 17.926 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.01 |
| AROONOSC (14) | 85.714 |
| WILLAMS %R (14) | -5.109 |
| MFI (14) | 78.462 |
ATYR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ATYR Price vs Max Options Open Interest
ATYR Max Change In Options Open Interest
ATYR Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ATYR Daily Out of Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ATYR Daily In the Money Options - Sort by Max open Interest (near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ATYR Most Active Options by Volume(near term)
1st February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
aTyr Pharma, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ATYR Moving Averages Analysis
aTyr Pharma, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
ATYR (aTyr Pharma, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.74 |
| 20 | 0.73 |
| 30 | 0.73 |
| 50 | 0.74 |
| 100 | 1.0 |
| 200 | 2.86 |
ATYR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 86.5 million |
| Earnings/Share ($) | -0.83 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.8175 |
| EPS Estimate Next Year ($) | -0.558 |
| WallStreet Target Price ($) | 4.3571 |
| Most Recent Quarter |